MedPath

Impact of Physiotherapy on sexual function in women with Stress Urinary Incontinence (SUI)

Not Applicable
Completed
Conditions
Topic: Reproductive Health and Childbirth/Stress Urinary Incontinence
Urological and Genital Diseases
Registration Number
ISRCTN09586238
Lead Sponsor
Sheffield Teaching Hospitals NHS Trust (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
114
Inclusion Criteria

1. Women aged 18-60 years must have given written (personally signed and dated) informed consent
2. Women who are able to understand, and are willing to comply with the requirements of the protocol
3. Women who are sexually active and are between the age of 18yrs and with urinary incontinence attending physiotherapy for pelvic floor muscle training (PFMT)
4. Women who score either greater than 25% on the urinary domain of the sexual function dimension, and/or greater than 33% for the degree of bother for the same symptom

Exclusion Criteria

1. Women with a prolapse as their predominant problem
2. Women who have had any previous incontinence surgery
3. Women who have a Grade 3 or above muscle strength as measured using the modified Oxford Scale on vaginal examination
4. Women with vaginal discharge or UTI
5. Women fitted with an implanted pacemaker
6. Women who are pregnant
7. Women with undiagnosed pelvic pain
8. Women with a known sensitivity to the electrodes or the electrode gel
9. Women with inflammation or infection of the vulva and vagina
10. Women who have experienced recent haemorrhage or haematoma
11. Women with atrophic vaginitis
12. Any other medical condition or abnormality (e.g. Malignancy or complication) that in the opinion of the investigator would impact upon the safety or efficacy of the study treatment or any study assessments
13. The patient is enrolled in another interventional trial
14. Non-English speaking women or with a specific language problem

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Physical dimension score (PISQ-31), at baseline and 6 months
Secondary Outcome Measures
NameTimeMethod
1. PISQ-31 Behavioral Emotive dimension and Partner-Related dimension scores<br>2. SF-36 domain scores<br>3. EQ-5
© Copyright 2025. All Rights Reserved by MedPath